Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment

Fig. 2

Change vs baseline in the HIT-6 score questionnaire from T6 to T18. Absolute HIT-6 Score reduction rate. The results show a positive and constant trend of reduction, and highlight the marked improvement in the QoL as demonstrated by a total HIT-6 score decrease of almost 12 points at T18 vs baseline (about 5 times higher the minimal important difference)

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us